Related Experiment Video
Updated: Jul 28, 2025

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
Published on: December 23, 2022
Patent foramen ovale closure in non-elderly and elderly patients with cryptogenic stroke: a hospital-based cohort
Po-Lin Chen1,2,3, Chi-Sheng Wang1, Jin-An Huang1,3,4
1Division of Neurology, Taichung Veterans General Hospital, Neurological Institute, Taichung, Taiwan.
Insights
Patent foramen ovale (PFO) closure reduced recurrent stroke and mortality in patients with cryptogenic stroke. Elderly patients undergoing PFO closure showed improved functional outcomes, suggesting its consideration in select older individuals.
Area of Science:
- Cardiology
- Neurology
- Medical Devices
Background:
- Patent foramen ovale (PFO) is a common cardiac anomaly.
- The efficacy of PFO closure in elderly patients with cryptogenic stroke (CS) remains unclear.
Purpose of the Study:
- To investigate the efficacy and safety of PFO closure in non-elderly and elderly patients with CS.
- To compare outcomes between PFO closure and medical management alone.
Main Methods:
- Prospective enrollment of patients (≥18 years) with CS/TIA and PFO.
- Classification into PFO closure (PFOC) and medical treatment (non-PFOC) groups.
- Primary outcome: composite of recurrent cerebral ischemic events and all-cause mortality; secondary outcome: modified Ranking Scale (mRS) at 180 days.
Main Results:
- PFO closure significantly reduced the primary outcome in the total cohort (6.2% vs. 17.1%, HR=0.35, p=0.043).
- Elderly patients with PFO closure showed a numerically lower risk of the primary outcome (HR=0.26, p=0.051) and better functional outcomes (lower median mRS, p=0.002).
- Safety outcomes were similar between groups and age categories.
Conclusions:
- PFO closure is associated with reduced risk of recurrent events in patients with PFO and CS.
- Elderly patients with PFO closure experience better functional outcomes.
- PFO closure may be a viable option for selected elderly patients with PFO.
Introduction:
The efficacy of patent foramen ovale (PFO) closure in the elderly population is unclear. We aimed to investigate the efficacy and safety of PFO closure in non-elderly and elderly patients.
Methods:
Patients over 18 years of age with cryptogenic stroke (CS) or transient ischemic attack and PFO were prospectively enrolled and classified into two groups according to treatment: (1) closure of PFO (the PFOC group) and (2) medical treatment alone (the non-PFOC group). The primary outcome was a composite of recurrent cerebral ischemic events and all-cause mortality during the follow-up period. A modified Ranking Scale [mRS] at 180 days was recorded. The safety outcomes were procedure-related adverse events and periprocedural atrial fibrillation. The results between the PFOC and non-PFOC groups in non-elderly (<60 years) and elderly (≥60 years) patients were compared.
Results:
We enrolled 173 patients, 78 (45%) of whom were elderly. During a mean follow-up of 2.5 years, the incidence of primary outcome was significantly lower in the PFOC group (6.2% vs. 17.1%, hazard ratio[HR] = 0.35, 95% CI 0.13-0.97, p = 0.043) in adjusted Cox regression analysis. Compared with the non-PFOC group, the PFOC group had a numerically lower risk of the primary outcome in both the elderly (HR 0.26, 95% CI 0.07-1.01, p = 0.051) and the non-elderly (HR 0.61, 95% CI 0.11-3.27, p = 0.574) groups. In addition, patients with PFO closure in the elderly group had a lower median mRS at 180 days (p = 0.002). The rate of safety outcome was similar between the non-elderly and elderly groups.
Discussion:
PFO closure was associated with a reduced risk of the primary outcome in patients with PFO and CS in our total cohort, which included non-elderly and elderly patients. Compared to those without PFO closure, elderly patients with PFO closure had a better functional outcome at 180 days. PFO closure might be considered in selected elderly patients with PFO.
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Mitral Stenosis II: Clinical features and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
Mitral Stenosis III: Medical Management
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Mitral Stenosis I: Introduction

